
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the latest turns in the Valeant Pharmaceuticals saga, the seeming inevitability of a Pfizer-Allergan merger, and Shire's up-and-down efforts to buy stuff it wants.
Fraud's not that big of a deal: the Valeant story, according to Bill Ackman is an episode from FierceBiotech Radio. Fierce editors discuss the latest turns in the Valeant Pharmaceuticals saga, the seeming inevitability of a Pfizer-Allergan...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Nov 5, 2015, 29:46 long, audio available.
Fierce editors discuss the latest turns in the Valeant Pharmaceuticals saga, the seeming inevitability of a Pfizer-Allergan merger, and Shire's up-and-down efforts to buy stuff it wants.
You can listen to Fraud's not that big of a deal: the Valeant story, according to Bill Ackman online on Radio and Podcast. Open the player on this page to stream the available audio.
Fraud's not that big of a deal: the Valeant story, according to Bill Ackman is an episode from FierceBiotech Radio.
This episode is 29:46 long.
This episode was published on Nov 5, 2015.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to Fraud's not that big of a deal: the Valeant story, according to Bill Ackman on this page when the episode audio is available from the podcast feed.
Fraud's not that big of a deal: the Valeant story, according to Bill Ackman is from FierceBiotech Radio.
Published Nov 5, 2015 and 29:46 long